Consumer price
JOD 5.99
▼ 8.0%from JOD 6.51
#26 of 31 by price
Product details
- Concentration
- 150 mg, 12.5 mg
- Packaging
- 30
- Manufacturer
-
Dar Al Dawa Development and Investment Co Ltd/Jordan
الاردن
- Brand owner
- Dar Al Dawa Development and Investment Co Ltd/Jordan
الاردن
- Distributor
-
Dar Al Dawa Development and Investment Co Ltdشركة دار الدواء للتنمية والأستثمار
- Registered
- —
Pricing · JOD
- Consumer
- JOD 5.99
- Previous
- JOD 6.51
- Pharmacist
- JOD 4.75
- Hospital
- —
- Sales tax
- JOD 0.24
- With tax
- JOD 6.23
Price history
2 distinct prices since tracking began
JOD 5.99 – 6.51
range
6.51 · before tracking5.99 · May 25 · 22:23
Competitive landscape
Every brand of Irbesartan
| Brand | Strength | Manufacturer | Price | |
|---|---|---|---|---|
Co-Irda 150mg/12.5 mg |
150 mg, 12.5 mg | NOBEL ILAC SANAYII VE TICARET A.S |
JOD 2.62 | View |
Irda 150mg F.C Tablets |
150 mg | NOBEL ILAC SANAYII VE TICARET A.S |
JOD 2.62 | View |
Co-Irda 300mg/12.5 mg |
300 mg, 12.5 mg | NOBEL ILAC SANAYII VE TICARET A.S |
JOD 3.11 | View |
Co-Irda 300mg/25mg F.C.T |
300 mg, 25 mg | NOBEL ILAC SANAYII VE TICARET A.S |
JOD 3.11 | View |
Irda 300mg F.C Tab |
300 mg | NOBEL ILAC SANAYII VE TICARET A.S |
JOD 3.11 | View |
Procard 150mg |
150 mg | JUBILANT GENERICS LIMITED/INDIA |
JOD 4.00 | View |
Procard 300mg |
300 mg | JUBILANT GENERICS LIMITED/INDIA |
JOD 4.00 | View |
Converium 150mg |
150 mg | MEDOCHEMIE LTD/CENTRAL FACTORY/CYPRUS |
JOD 4.36 | View |
Converium 300mg |
300 mg | MEDOCHEMIE LTD/CENTRAL FACTORY/CYPRUS |
JOD 4.36 | View |
Procard Plus 150/12.5 |
150 mg, 12.5 mg | Al-Taqqadom Pharmaceutical Industries |
JOD 4.38 | View |
Irbegen 150mg |
150 mg | Genepharm S.A |
JOD 4.40 | View |
Irbegen 300mg |
300 mg | Genepharm S.A |
JOD 4.40 | View |
Irbegen Plus 150/12.5 mg |
150 mg, 12.5 mg | Genepharm S.A |
JOD 4.72 | View |
Irbegen Plus 300/12.5mg |
300 mg, 12.5 mg | Genepharm S.A |
JOD 4.72 | View |
Irbegen Plus 300/25mg |
300 mg, 25 mg | Genepharm S.A |
JOD 4.72 | View |
Signals on this product
registered
New registration: Gizlan -Plus 150mg/12.5mg (Irbesartan 150 mg, Hydrochlorothiazide 12.5 mg)
May 25 · 22:23
Raw JFDA record
{
"ATCCODE": "C09DA04",
"CLASSIFICATION_CODE": 0,
"CLASSIFICATION_NAME": null,
"COMPANY_DESC_A": "Dar Al Dawa Development and Investment Co Ltd/Jordan",
"CONC_UNIT": null,
"COUNTRY_DESC_A": "\u0627\u0644\u0627\u0631\u062f\u0646",
"DOSAGEFORM": null,
"DRG_BARCODE": "6251107378217",
"DRG_BARCODE_SER": "57728",
"DRG_B_R_CMP_CODE": null,
"DRG_B_R_CMP_COUNTRY_CODE": 0,
"DRG_CAN_TYPE": 0,
"DRG_CLASS_TYPE": 0,
"DRG_CODE": 57728,
"DRG_CONCENTRATE": "150 mg, 12.5 mg",
"DRG_CURRENCY_TRANSFORM_FAC": 0,
"DRG_CURRENT_HOSP_PRICE": 0,
"DRG_CURRENT_JORD_CITIZEN_PRICE": 5.99,
"DRG_CURRENT_JORD_PHARM_PRICE": 4.75,
"DRG_DESC_A": null,
"DRG_DESC_L": "Gizlan -Plus 150mg/12.5mg",
"DRG_DEST_STORE_PRICE": 0,
"DRG_EXPORT_CURRENCY_CODE": 0,
"DRG_EXPORT_PRICE": null,
"DRG_FILLING": "30",
"DRG_INDUST_CMP": null,
"DRG_INDUST_CMP_CODE": 23514,
"DRG_INDUST_CMP_COUNTRY": null,
"DRG_INDUST_CMP_COUNTRY_CODE": 35,
"DRG_JORD_PRICE_ORG_CONT": 0,
"DRG_JORD_PRICE_ORG_FAC": 0,
"DRG_JORD_PRICE_ORG_HOSP": 0,
"DRG_LEAGUE_DATE": "/Date(-62135596800000)/",
"DRG_LOCAL_FLAG": 1,
"DRG_MEDICAL_CLASSIFICATION": null,
"DRG_NATURE": 2,
"DRG_ORIGIN_CAN_SIZE": 0,
"DRG_ORIGIN_CITIZEN_CURRENCY": null,
"DRG_ORIGIN_CITIZEN_PRICE": null,
"DRG_ORIGIN_CONT_CODE": 0,
"DRG_ORIGIN_CONT_HOSP": 0,
"DRG_ORIGIN_CONT_HOSP_CUR": 0,
"DRG_ORIGIN_FACTORY_CURRENCY": 0,
"DRG_ORIGIN_FACTORY_PRICE": null,
"DRG_ORIGIN_NET_COUNTRY": 0,
"DRG_ORIGIN_NET_CURRNCY": 0,
"DRG_ORIGIN_NET_PRICE": 0,
"DRG_ORIG_FAC_CONT_CODE": 0,
"DRG_ORIG_HOS_CONT_CODE": 0,
"DRG_PRICE_ACTIVEDATE": null,
"DRG_PRICE_PREVPRICE": 0,
"DRG_PRICE_PREVPRICE_WTAX": null,
"DRG_PRIMARY_CMP_CODE": 0,
"DRG_PRIMARY_CMP_COUNTRY_CODE": 0,
"DRG_PRV_HOSP_PRICE": 0,
"DRG_PRV_JORD_CITIZEN_PRICE": 6.51,
"DRG_PRV_JORD_PHARM_PRICE": 5.17,
"DRG_REGION_CODE": 0,
"DRG_REGION_FAC": -1,
"DRG_REG_NO": null,
"DRG_REG_NO1": null,
"DRG_REG_NO2": 0,
"DRG_REMARK": null,
"DRG_RENUAL_NO": null,
"DRG_RENUAL_NO1": null,
"DRG_RENUAL_NO2": 0,
"DRG_RENUAL_NO3": 0,
"DRG_RENUAL_NO4": 0,
"DRG_SALES_CMP_CODE": 0,
"DRG_SALES_CMP_NAME": null,
"DRG_SALES_COUNTRY_CODE": "35",
"DRG_SALES_TAX": 0.24,
"DRG_SAUDI_COMPARISON_FALG": 0,
"DRG_SCIENTIFIC_STRUCTURE": null,
"DRG_SECONDARY_CMP_CODE": 0,
"DRG_SECONDARY_CMP_COUNTRY_CODE": 0,
"DRG_SHIP_CMP_CODE": 0,
"DRG_SHIP_TYPE": null,
"DRG_STORE_CODE": 63,
"DRG_TAXED_HOSP_PRICE": 0,
"DRG_TAXED_JORD_CITIZEN_PRICE": 6.23,
"DRG_TYPE": 1,
"DRG_TYPE_DESC": null,
"DRG_USERID_DEL_CODE": null,
"DRG_USERID_DEL_DATE": "/Date(-62135596800000)/",
"DRG_USERID_INS_CODE": null,
"DRG_USERID_INS_DATE": "/Date(-62135596800000)/",
"DRG_USERID_UPD_CODE": null,
"DRG_USERID_UPD_DATE": "/Date(-62135596800000)/",
"DRUG_DISCOUNT_FLAG": 0,
"DRUG_GROUP_ID": 0,
"DRUG_ROUTE": null,
"ERRORDESC": null,
"EXPIRY": null,
"GENERICNAME": null,
"INGREDIENT": null,
"INGREDIENTS": "Irbesartan 150 mg, Hydrochlorothiazide 12.5 mg",
"INGRLKP_NAME": null,
"INGR_SOURCE": null,
"INSERTED_DATE": "/Date(-62135596800000)/",
"INVOICER": "DAD",
"ISSUE_CODE": 0,
"JHP": 0,
"JPP": 0,
"LEAFLET_RD": null,
"LIST_CLASSIFICATION": null,
"LIST_CODE": 0,
"LIST_NAME": null,
"MAH_E": "Dar Al Dawa Development and Investment Co Ltd/Jordan",
"MARKETED_FLAG": 0,
"MODELSTA": false,
"Marketing_Country": "\u0627\u0644\u0627\u0631\u062f\u0646",
"RATIONAL_FLAG": 0,
"RECORD_CURRENT_STATUS": 0,
"RECORD_CURRENT_STATUS_DESC": null,
"RECORD_STATUS": 0,
"RECORD_STATUS_DESC": null,
"RECORD_TYPE_CODE": 0,
"RECORD_TYPE_DESC": null,
"REGISTRATION_DATE": "/Date(-62135596800000)/",
"REGISTRATION_DECISION_DATE": "/Date(-62135596800000)/",
"REGISTRATION_REQUEST_DATE": "/Date(-62135596800000)/",
"REGISTRATION_REQUEST_NUMBER": null,
"REG_REQ_DATE": null,
"RE_REGISTRATION_DATE": "/Date(-62135596800000)/",
"SHIP_TYPE_DESC": null,
"SREGISTRATION_DATE": null,
"SRE_REGISTRATION_DATE": null,
"STORES_DESC_A": "\u0634\u0631\u0643\u0629 \u062f\u0627\u0631 \u0627\u0644\u062f\u0648\u0627\u0621 \u0644\u0644\u062a\u0646\u0645\u064a\u0629 \u0648\u0627\u0644\u0623\u0633\u062a\u062b\u0645\u0627\u0631",
"STORES_DESC_L": "Dar Al Dawa Development and Investment Co Ltd",
"STORING_CONDITIONS": null,
"TypeGroup": null,
"UPDATED_DATE": "/Date(-62135596800000)/",
"ingname": null,
"lDrugCompany": null,
"leaflet_file_name": null,
"lstDrug": null,
"lstDrugLog": null,
"lstIngredients": null,
"lstStore": null,
"message": null,
"nature": null,
"title": null
}